![Common Stock](/common/images/company/TX_NEM.png)
Roche Holding AG (ROG.VX) Wednesday said its subsidiary Bryce Acquisition Corporation accepted for payment all shares tendered pursuant to its offer for all outstanding shares of Anadys...
NEW YORK, NY -- (Marketwire) -- 11/08/11 -- Biotech companies focused on treatment for Hepatitis C have been on the upswing in recent weeks as a combination of acquisitions and positive test...
Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights PR Newswire SAN DIEGO, Nov. 7, 2011 SAN DIEGO, Nov. 7, 2011 /PRNewswire/ -- Anadys Pharmaceuticals, Inc...
NEW YORK, NY -- (Marketwire) -- 10/26/11 -- Drug approvals from administrative bodies in both the U.S. and Europe have been pivotal for biotech companies recently. Investors have been...
Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Anadys Pharmaceticals, Inc. (“Anadys” or the “Company”...
Roche Holding AG (ROG.VX) Thursday gave investors fresh evidence its drug universe is expanding beyond the core cancer franchise, after the Swiss giant said long-term data showed...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Anadys Pharmaceuticals, Inc. (“Anadys” or the...
Levi & Korsinsky is investigating the Board of Directors of Anadys Pharmaceuticals Inc. (“Anadys” or the “Company”) (NASDAQ: ANDS) for possible breaches of fiduciary duty and...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Anadys Pharmaceticals, Inc. (“Anadys” or the “Company”...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.